Krystal Biotech, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $209.0M
Liabilities Breakdown FY2019
Total Liabilities: $6.1M
Asset Breakdown
Total Assets: $209.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $187.5M | 89.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $8.5M | 4.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $13.0M | 6.2% |
Liabilities Breakdown
Total Liabilities: $6.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.0M | 16.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.1M | 83.3% |